Showing 9441-9450 of 18560 results for "".
- Innovative Strides in Malaria Vaccines and Treatments: Mimicking Immunity and Enhancing Drug Efficacyhttps://reachmd.com/news/innovative-strides-in-malaria-vaccines-and-treatments-mimicking-immunity-and-enhancing-drug-efficacy/2476125/Researchers are intensifying the battle against malaria, unveiling vaccine and chemical advances that promise to outpace the parasite’s ability to evade current interventions. At the vanguard is the R21/Matrix-M malaria vaccine, which enhances natural immunity by gen
- The Evolution of Surgical Techniques in Endometrial Cancer: From Laparotomy to Innovationhttps://reachmd.com/news/the-evolution-of-surgical-techniques-in-endometrial-cancer-from-laparotomy-to-innovation/2476095/As surgical techniques for endometrial cancer continue reshaping oncologic practice, the move from open laparotomy toward minimally invasive surgery is forging a new era of precision and patient-centered care. Building on decades of open surgery, a landmark
- Molecular Interventions for Treatment-Resistant Nephrotic Syndrome Focus on cdc42https://reachmd.com/news/molecular-interventions-for-treatment-resistant-nephrotic-syndrome-focus-on-cdc42/2476083/Amid rising rates of treatment-resistant nephrotic syndrome, relentless proteinuria demands novel interventions—molecular targets like cdc42 now command attention for their potential to reshape therapy. Nephrologists often grapple with patients whose proteinuria persists despite maxi
- Innovative Approaches to Combat Antibiotic Resistance: Phage Therapy and Long-Acting Antibioticshttps://reachmd.com/news/innovative-approaches-to-combat-antibiotic-resistance-phage-therapy-and-long-acting-antibiotics/2476091/A paradigm shift is under way as clinicians explore how bacteriophages—viruses that specifically infect bacteria—can evolve alongside resistant pathogens, potentially outpacing the arms race of antibiotic resistance; however, phage therapy remains investigational and is primarily administer
- Frontline Immunity: Universal Vaccine Development Against Evolving Pathogenshttps://reachmd.com/news/frontline-immunity-universal-vaccine-development-against-evolving-pathogens/2476085/Frontline clinicians and infectious disease specialists face an onslaught of antigenically drifting viruses and novel zoonoses that outpace pathogen-specific defenses; universal vaccine development and integrated antiviral measures promise the broad-spectrum immunity needed to stay ahead of
- Reshaping Mental Health: COVID-19’s Dual Impact Through Stress and Geneticshttps://reachmd.com/news/reshaping-mental-health-covid-19s-dual-impact-through-stress-and-genetics/2476080/The global COVID-19 pandemic is reshaping how clinicians understand mood and anxiety disorders, revealing ongoing interactions between prolonged external stressors and underlying genetic predispositions. Building on this urgency, older adults have experienced a marked rise in depress
- Integrating GLP-1 Receptor Agonists in Comprehensive Obesity Managementhttps://reachmd.com/news/integrating-glp-1-receptor-agonists-in-comprehensive-obesity-management/2476071/GLP-1 receptor agonists enhance weight loss through multiple pathways. Agents such as liraglutide and semaglutide improve glycemic control, delay gastric emptying, and suppress appetite. A
- Innovative Strategies Against Immune Evasion in HNSCChttps://reachmd.com/news/innovative-strategies-against-immune-evasion-in-hnscc/2476078/The battle against cancer often feels like a never-ending struggle, especially as tumor cells develop cunning strategies to evade the immune system. In head and neck squamous cell carcinoma (HNSCC), immune evasion presents a significant challenge to treatment efficacy, demanding inn
- JAK Inhibitors in Dermatology: Transforming Autoimmune Pathwayshttps://reachmd.com/news/jak-inhibitors-in-dermatology-transforming-autoimmune-pathways/2476079/In dermatology, JAK inhibitors are rapidly emerging as potent agents in managing autoimmune conditions refractory to conventional therapies. By targeting the JAK-STAT pathway, these drugs offer a novel mechanism for modulating immune responses in granulomatous and other autoimmune skin dise
- Alzheimer's 2025: Embracing Immunomodulatory Microglia Strategieshttps://reachmd.com/news/alzheimers-2025-embracing-immunomodulatory-microglia-strategies/2476076/The 2025 Alzheimer's Consortium guidelines now emphasize immunomodulatory strategies targeting microglial activation, marking a departure from solely amyloid-centric approaches. As the brain’s resident immune sentinels, microglia orchestrate inflammatory cascades and amyloid clearanc